Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 19696 AL 19710

[Animal models of Alzheimer's disease for preclinical research.]

Takahashi H.

Nihon Yakurigaku Zasshi. 2010 Jul;136(1):6-10. doi: 10.1254/fpj.136.6.

[Pharmacological properties of T-817MA, a novel neurotrophic agent, for treatment of Alzheimer's disease.]

Fukushima T.

Nihon Yakurigaku Zasshi. 2010 Jul;136(1):11-4. doi: 10.1254/fpj.136.11.

[Progress in the development of anti-amyloid drugs for treatment of Alzheimer's disease.]

Shitaka Y, Mitani Y, Nagakura A, Miyake A, Matsuoka N.

Nihon Yakurigaku Zasshi. 2010 Jul;136(1):15-20. doi: 10.1254/fpj.136.15.

[Current status of Alzheimer's disease immunotherapy and pharmacologic effect of BAN2401.]

Araki S.

Nihon Yakurigaku Zasshi. 2010 Jul;136(1):21-5. doi: 10.1254/fpj.136.21.

The PSEN1 I143T mutation in a Swedish family with Alzheimer's disease: clinical report and quantification of Aβ in different brain regions

Keller L, Welander H, Chiang HH, Tjernberg LO, Nennesmo I, Wallin AK, Graff C.

Eur J Hum Genet. 2010 Nov;18(11):1202-8. doi: 10.1038/ejhg.2010.107. Epub 2010 Jul 14.

Beta amyloid aggregation inhibitors: small molecules as candidate drugs for therapy of Alzheimer's disease

Re F, Airoldi C, Zona C, Masserini M, La Ferla B, Quattrocchi N, Nicotra F.

Curr Med Chem. 2010;17(27):2990-3006. doi: 10.2174/092986710791959729.

Kynurenines, neurodegeneration and Alzheimer's disease

Kincses ZT, Toldi J, Vécsei L.

J Cell Mol Med. 2010 Aug;14(8):2045-54. doi: 10.1111/j.1582-4934.2010.01123.x. Epub 2010 Jul 12.

Neuropathology after active Abeta42 immunotherapy: implications for Alzheimer's disease pathogenesis

Boche D, Denham N, Holmes C, Nicoll JA.

Acta Neuropathol. 2010 Sep;120(3):369-84. doi: 10.1007/s00401-010-0719-5. Epub 2010 Jul 15.

Neuroinflammatory processes in Alzheimer's disease

Heneka MT, O'Banion MK, Terwel D, Kummer MP.

J Neural Transm (Vienna). 2010 Aug;117(8):919-47. doi: 10.1007/s00702-010-0438-z. Epub 2010 Jul 15.

Role of by-products of lipid oxidation in Alzheimer's disease brain: a focus on acrolein

Singh M, Dang TN, Arseneault M, Ramassamy C.

J Alzheimers Dis. 2010;21(3):741-56. doi: 10.3233/JAD-2010-100405.

A review of string vessels or collapsed, empty basement membrane tubes

Brown WR.

J Alzheimers Dis. 2010;21(3):725-39. doi: 10.3233/JAD-2010-100219.

Comparison of conventional ELISA with electrochemiluminescence technology for detection of amyloid-β in plasma

Oh ES, Mielke MM, Rosenberg PB, Jain A, Fedarko NS, Lyketsos CG, Mehta PD.

J Alzheimers Dis. 2010;21(3):769-73. doi: 10.3233/JAD-2010-100456.

Effect of donepezil on cognition in severe Alzheimer's disease: a pooled data analysis

Cummings J, Jones R, Wilkinson D, Lopez O, Gauthier S, Waldemar G, Zhang R, Xu Y, Sun Y, Richardson S, Mackell J.

J Alzheimers Dis. 2010;21(3):843-51. doi: 10.3233/JAD-2010-100078.

Immunotherapy and neuroimmunology in Alzheimer's disease: a perspective from the blood-brain barrier

Banks WA.

Immunotherapy. 2010 Jan;2(1):1-3. doi: 10.2217/imt.09.72.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias